FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
An intestinal pathogen reshapes the gut environment to fuel its own colonization and cause diseases, a multi-institutional ...
Duke researchers help reprogram immune cells inside the body, potentially expanding access to cancer therapies The following ...
Scientists reprogram brain cells to remove Alzheimer’s plaques with a single injection, showing a new approach to long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results